Sarepta Therapeutics(DE:AB3A)
€13.72-0.66 (-4.59%)
DE:AB3A
Sarepta Therapeutics earnings date
€13.72
At close:-0.66 (-4.59%)
Sarepta Therapeutics (AB3A) Q1 2025 Earnings Report
6 Followers
DE:AB3A Q1 2025 EPS Results
- Actual EPS
- -EUR 4.19
- Consensus EPS
- -EUR 2.92
- Beat/Miss
- Missed by -EUR 1.27
- One Year Ago EPS
- EUR 0.34
DE:AB3A Q1 2025 Revenue Results
- Actual Revenue
- EUR 679.00M
- Expected Revenue
- EUR 626.68M
- Beat/Miss
- Beat by +EUR 52.31M
- YoY Revenue Growth
- +80.15%
Earnings Announcement Details
- Quarter
- Q1 2025
- Date
- 05/06/2025
- Time
- After Close
- Conference Call
- Tuesday, May 6, 2025
DE:AB3A Upcoming Earnings
Sarepta Therapeutics's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q1 2025 Earnings Call Audio
DE:AB3A Q1 2025 Earnings Call
0:00 / 0:00
Q1 2025 Earnings Slide Deck
Q1 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AB3A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.34- | -3.58 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.07-0.25 | -1.64 | 85.00% (+1.39) | |
| Aug 05, 2026 | 2026 (Q2) | 0.20-0.05 | 1.72 | -102.65% (-1.77) | |
| May 06, 2026 | 2026 (Q1) | 0.892.63 | -4.19 | 162.61% (+6.82) | |
| Feb 25, 2026 | 2025 (Q4) | -1.09-3.58 | 1.37 | -362.00% (-4.95) | |
| Nov 03, 2025 | 2025 (Q3) | -0.66-1.64 | 0.31 | -629.41% (-1.95) | |
| Aug 06, 2025 | 2025 (Q2) | 0.761.72 | 0.06 | 2600.00% (+1.66) | |
| May 06, 2025 | 2025 (Q1) | -2.92-4.19 | 0.34 | -1343.24% (-4.53) | |
| Feb 26, 2025 | 2024 (Q4) | 1.721.37 | 0.43 | 219.15% (+0.94) | |
| Nov 06, 2024 | 2024 (Q3) | -0.070.31 | -0.42 | 173.91% (+0.73) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


